Inventor · disambiguated record
Ronald E. White
Also filed as: WHITE RONALD E · WHITE RONALD EUGENE · WRIGHT GEORGE C
34 granted patents·7 pending applications·1,142 citations·filing 1977–2010
97Inventor score
Files withMORTON NORWICH PRODUCTS INC9PROCTER & GAMBLE9NORWICH EATON PHARMA5GHOSAL ANIMA3PROCTER & GAMBLE PHARMA3
Top patents by PatentIndex Score
41 records- 0198US6895965B2Customizable seal, mask with customizable seal and method of using such a sealRESPIRONICS INC·Filed 2002·Granted May 24, 2005·363 cites·6 claims
- 0298US6397847B1Customizable seal, mask with customizable seal and method of using such a sealRESPIRONICS INC·Filed 1999·Granted Jun 4, 2002·353 cites·22 claims
- 0394US7870859B2Patient contacting seal and mask using sameRIC INVESTMENTS LLC·Filed 2005·Granted Jan 18, 2011·27 cites·4 claims
- 0491US8485190B2Patient contacting seal and mask using sameBARNETT SHARI S·Filed 2010·Granted Jul 16, 2013·18 cites·15 claims
- 0591US5491139AAntimicrobial quinolonyl lactamsPROCTER & GAMBLE·Filed 1994·Granted Feb 13, 1996·50 cites·35 claims
- 0690US5180719AAntimicrobial quinolonyl lactam estersNORWICH EATON PHARMA·Filed 1991·Granted Jan 19, 1993·50 cites·29 claims
- 0789US5646163AQuinolone 5-(N-heterosubstituted amino) antimicrobialsPROCTER & GAMBLE·Filed 1994·Granted Jul 8, 1997·38 cites·20 claims
- 0885US5631256AAntimicrobial quinolone thioureasPROCTER & GAMBLE·Filed 1994·Granted May 20, 1997·26 cites·29 claims
- 0981US5328908AAntimicrobial quinolone thioureasPROCTER & GAMBLE PHARMA·Filed 1990·Granted Jul 12, 1994·21 cites·26 claims
- 1077US5387748AAntimicrobial dithiocarbamoyl quinolonesPROCTER & GAMBLE PHARMA·Filed 1991·Granted Feb 7, 1995·33 cites·35 claims
- 1175US5656623AAntimicrobial lactam-quinolonesPROCTER & GAMBLE·Filed 1991·Granted Aug 12, 1997·25 cites·101 claims
- 1273US5281703AProcess for making antimicrobial quinolonyl lactamsPROCTER & GAMBLE PHARMA·Filed 1993·Granted Jan 25, 1994·30 cites·17 claims
- 1369US8141682B2Security cone-door for a ladderWHITE RONALD E·Filed 2009·Granted Mar 27, 2012·4 cites·7 claims
- 1467US5273973AAntimicrobial quinolonyl estersNORWICH EATON PHARMA·Filed 1992·Granted Dec 28, 1993·9 cites·29 claims
- 1566US5646139AAntimicrobial carbapenem quinolonesPROCTER & GAMBLE·Filed 1995·Granted Jul 8, 1997·18 cites·31 claims
- 1665US5648346AAntimicrobial carbacephem-quinolonesPROCTER & GAMBLE·Filed 1995·Granted Jul 15, 1997·17 cites·39 claims
- 1765US5637580AAntimicrobial penem-quinolonesPROCTER & GAMBLE·Filed 1995·Granted Jun 10, 1997·17 cites·46 claims
- 1865US5530116AAntimicrobial quinolonyl lactamsPROCTER & GAMBLE·Filed 1994·Granted Jun 25, 1996·9 cites·30 claims
- 1962US4424367A5-(4-Aminophenyl)-2-thiophenecarboximidamide hydrochloride hemihydrateNORWICH EATON PHARMA·Filed 1982·Granted Jan 3, 1984·4 cites·1 claims
- 2057US7504517B2Kv1.5 potassium channel inhibitorsWYETH CORP·Filed 2007·Granted Mar 17, 2009·0 cites·30 claims
- 2156US7803827B2Kv1.5 potassium channel inhibitorsWYETH LLC·Filed 2008·Granted Sep 28, 2010·0 cites·69 claims
- 2256US2008029340A1Security cone-door for a ladderWHITE RONALD E·Filed 2006·Application pending·0 cites
- 2355US4291163ADecahydroquinoline-2-carboxylic acid compoundsMORTON NORWICH PRODUCTS INC·Filed 1980·Granted Sep 22, 1981·3 cites·1 claims
- 2453US4070380A5-(4-Amidinophenyl)-2-furamidine dihydrochloride monohydrateMORTON NORWICH PRODUCTS INC·Filed 1977·Granted Jan 24, 1978·2 cites·1 claims
- 2553US4066670AN-dimethylaminopropyl-5-(2-nitrophenyl)-2-furancarboximidamide dihydrochloride monohydrateMORTON NORWICH PRODUCTS INC·Filed 1977·Granted Jan 3, 1978·2 cites·1 claims
- 2652US2007207949A1Medicaments and methods combining a HCV protease inhibitor and an AKR competitorGHOSAL ANIMA·Filed 2006·Application pending·0 cites
- 2751US2007232527A1Medicaments and methods combining a HCV protease inhibitor and an AKR competitorGHOSAL ANIMA·Filed 2006·Application pending·0 cites
- 2850US5672600AAntimicrobial dithiocarbamoyl quinolonesPROCTER & GAMBLE·Filed 1994·Granted Sep 30, 1997·7 cites·33 claims
- 2950US2007287664A1Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related theretoSCHERING CORP·Filed 2007·Application pending·0 cites
- 3047US2007021351A1Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitorSCHERING CORP·Filed 2006·Application pending·0 cites
- 3144US4374246A1-N-[(1-Carboxy-3-phenylpropyl)glycyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acid compoundsNORWICH EATON PHARMA·Filed 1981·Granted Feb 15, 1983·1 cites·3 claims
- 3240US5457430AMethod and apparatus for reduction of light intensity decay in optical pumping devicesBALL CORP·Filed 1994·Granted Oct 10, 1995·11 cites·39 claims
- 3340US2010291034A1Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related theretoSCHERING CORP·Filed 2010·Application pending·0 cites
- 3440US2006276404A1Medicaments and methods combining a HCV protease inhibitor and an AKR competitorGHOSAL ANIMA·Filed 2006·Application pending·0 cites
- 3539US4370494AConverting enzyme inhibitorsNORWICH EATON PHARMA·Filed 1982·Granted Jan 25, 1983·4 cites·1 claims
- 3637US4200756AMethyl 3-(3-ethylureido)-1,2,5,6-tetrahydro-2-oxopyridine-4-carboxylateMORTON NORWICH PRODUCTS INC·Filed 1978·Granted Apr 29, 1980·0 cites·1 claims
- 3737US4182890AEthyl 2-oxo-3-phenylethylaminopiperidine-4-carboxylate hydrochlorideMORTON NORWICH PRODUCTS INC·Filed 1978·Granted Jan 8, 1980·0 cites·1 claims
- 3837US4178452AEthyl 3-[(3,4-dimethoxyphenyl)ethylamino]-1,2,5,6-tetrahydro-2-oxopyridine-4-carboxylateMORTON NORWICH PRODUCTS INC·Filed 1978·Granted Dec 11, 1979·0 cites·1 claims
- 3936US4217286A5-Phenyl-2-furancarboximidamidesMORTON NORWICH PRODUCTS INC·Filed 1977·Granted Aug 12, 1980·0 cites·2 claims
- 4036US4078141A5-(2-Nitrophenyl)-2-furancarboximidoyl morpholine or pyrrolidine hydrochlorideMORTON NORWICH PRODUCTS INC·Filed 1977·Granted Mar 7, 1978·0 cites·3 claims
- 4136US4059597A1-[5-(2-Nitrophenyl)-2-furancarboximidoyl]-1H-hexahydroazepine hydrochlorideMORTON NORWICH PRODUCTS INC·Filed 1977·Granted Nov 22, 1977·0 cites·1 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →